For more than 25 years, the Reproductive Health Technologies Project (RHTP) worked to advance the ability of every woman to achieve full reproductive freedom with access to the safest, most effective, appropriate, and acceptable technologies for ensuring her own health and determining whether, when, and how to have children. RHTP has done this work by seeking consensus through a process of dialogue among diverse communities about technological developments and their implications.
After careful consideration, the Board of Directors decided in fall of 2016 to bring RHTP’s operations to a close. In part because of RHTP’s own contributions to the field, the organization’s particular role has become less essential than it once was. RHTP is proud that its core work to directly address and move past impasses where science and politics meet, and often clash, is now widely recognized as a standard approach to research and advocacy efforts to increasing access to reproductive technologies.
RHTP was founded in 1988 as a working group to provide public education and build public understanding about the French “abortion pill” RU 486 and other antiprogestins. In 1992, RHTP became an independent 501(c)3 organization. Taking on issues where science, politics, and industry converged — and often clashed — RHTP established itself as a powerful vehicle for public education, advocacy, and policy development around existing and emerging reproductive health technologies. Throughout its history, RHTP applied its winning approach to advocacy and consensus-building: bringing together experts from a variety of fields and disciplines to learn from and influence one another, using solid science and clinical data to arm advocates and policy makers to influence political outcomes, and developing strategies on cutting edge issues that could be carried out by the broadest possible range of organizations and constituencies.